期刊文献+

肝癌组织中浸润树突状细胞的数量和表面分子表达的临床意义 被引量:1

CLINICAL SIGNIFICANCE OF DENDRITIC CELLS INFILTRATION AND SURFACE MOLECULES EXPRESSION IN HEPATOCELLULAR CARCINOMA
下载PDF
导出
摘要 目的:研究人肝癌组织中浸润树突状细胞(DC)的数量和表面分子表达的临床意义。方法:原发性肝细胞癌(肝癌)术后组织标本30例,采用免疫组化方法(即用型两步法SupervisionTM)检测肝癌组织中DC标志蛋白S-100的表达;从肝癌组织中分离浸润性单个核细胞,流式细胞术检测DC的表面分子表达,并用RT-PCR技术检测肝癌组织IL-10、TGF-β1和VEGF-AmRNA。结果:肝癌组织中DC的数量少,高分化肝癌组织中DC浸润数量[(27.22±15.38)个/HPF]高于低分化肝癌[(11.92±8.56)个/HPF](P<0.01);肝癌组织中浸润DC的表面分子如CDla、HLA-DR、CD80、CD86和CD54等MHC-Ⅰ、Ⅱ类分子,共刺激分子和黏附分子存在低表达或不表达,与肝癌的分化程度密切相关。在mRNA水平上,IL-10、TGF-β1和VEGF-A基因在肝癌组织中的表达显著高于正常肝组织(P<0.001,P<0.05)。结论:肝癌组织中浸润DC的数量减少并存在功能缺陷,与肝癌分化程度密切相关。 Objective: To investigate the clinical significance of dendritic cells infiltration and surface molecules in human hepatocellular carcinoma (HCC). Methods: 30 cases of HCC were studied with immunohistochemical staining , surface molecules of infiltrating DC were examined by methods including cells isolation and FACS. Reverse transcript-polymerase chain reaction (RT-PCR) was used to detect IL-10, TGF-β1 and VEGF-A mRNA expression in HCC tissue. Result: The number of infiltrating DC in HCC decreased, and the number of DC infiltration in the group with good differentiationE(27.22±15.38)个/HPF] was significantly higher than that in the group with poor differentiation [(11.92±8.56)个/HPF] ( P 〈0.01). The levels of some surface molecules such as MHC class Ⅰ (CDla) and Ⅱ (HLA-DR), and constimulating molecules (CD80, CD86), and adhesion molecules(CD54) in HCC were down-regulated or negative. In the mRNA level,the expressions of IL-10, TGF-β1 and VEGF-A gene in HCC tissue were higher than those of normal liver tissue( P 〈0. 001, P 〈0.05). Conclusion: The infiltrating DC of HCC decreased, and it was a kind of dysfunction DC and was closely linked to differentiation degree of HCC.
出处 《广西医科大学学报》 CAS 北大核心 2007年第3期345-348,共4页 Journal of Guangxi Medical University
基金 国家自然科学基金资助项目(No30360114) 广西自然科学基金资助项目(No0448069)
关键词 肝癌 树突状细胞 细胞表面分子 hepatocellular carcinoma dendritic cells cell surface molecules
  • 相关文献

参考文献8

  • 1Engleman EG. Dendritic cell-based cancer immunotherapy. Sermin Oncol, 2003,30(Suppl 8) : 23-29.
  • 2Cai XY, Gao Q, Qiu SJ, et al. Dendritic cell infiltration and prognosis of human hepatocellular carcinoma. J Cancer Res Clin Oncol, 2006,19:1-9.
  • 3刘崇东,张震宇,王淑珍,夏成青.S-100阳性树突状细胞在卵巢上皮癌组织中的分布及意义[J].肿瘤防治杂志,2004,11(3):233-236. 被引量:5
  • 4Nagaraj S, Ziske C, Schmidt-Wolf IG. Dendritic cell, the immunotherapeutic cell for cancer. Indian J Med Res, 2004, 119(4): 133-138.
  • 5Banchereau J, Palucka AK. Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol, 2005,5(4): 296-306.
  • 6Tarte K, klein B. Dendritic cell-based vaccine: a promising approach for cancer immunotherapy. Blood Reviews, 1999,13 : 51-64.
  • 7D'Orazio TJ , Niederkorn JY . A novel role for TGF-beta and IL-10 in the induction of immune privilege. J Immunol,1998, 160(5):2 089-2 098.
  • 8Mitsuhiko Iwamoto, Hisashi Shiohara. Prognostic value of tumor- infiltrating dendritic cells expression CD83 in human breast carcinoma. Int J Cancer, 2003,104 : 92-97.

二级参考文献11

  • 1Tsuge T, Yamakawa M,Tsukamoto M. Infiltrating dentritic/Langerhans cells in primary cancer[J]. Breast Cancer Res Treat,2000,59(2): 141 152.
  • 2Nakano T,Oka K,Takahashi T,et al. Roles of Langerhang cells and T-lymphocytes infiltrating cancer tissues in patients treated by radiation therapy for cervical cancer[J]. Cancer, 1992,70(3):2839-2844.
  • 3Ameb K, Mori M. Enjoji M S-100 protein-posistive dendritic cells in colorectal adenocarcinomas [J]. Cancer, 1989, 63 (8):496- 503.
  • 4Imai Y, Yamakawa M. Dendritic cells in esophageal cancer and lymph node tissues[J]. In Vitro, 1993,7(3):239-248.
  • 5Ikeguchi M, Ikeda M, Tatebe S, et al. Clinical significance of dendritic cell infiltration esophageal squamous cell carcinoma[J]. OncolRep,1998,5(5): 1185- 1189.
  • 6Inoue K Furihata M, Ohtsukiy, et al. Distribution of S-100 pro tein-positive dendritic cells and expressin of HLA DR antigen in transitional cell carcinoma cf tumor progression and prognosis[J]. Virchoow Archh A Pathol A nat Histopathol, 1993,422(5):351-3
  • 7Takahashi K. Yamaguchi H,Ishizeki J,et al. Immunohisto chemical and immunoelectron microscopic localization of S-100 protein in the interdigitating reticulum cells of the human lymph node[J]. Virchows Arch,1981,37(2) :125-135.
  • 8Kakeji Y,Maehara Y,Korenaga D,et al. Prognostic significance of tumor-host interaction in clinical gastric cancer : relationship between DNA ploidy and dendritic cell infiltration[J]. J Surg Oncol, 1993,52(4) :207-212.
  • 9Steinman R M. The dendritic cell system and it is role in immu nogenecity[J]. Annu Rev Immunol,1991,9:271-296.
  • 10曹泽毅.中华妇产科学[M].北京:人民卫生出版社,1999.2129.

共引文献4

同被引文献12

  • 1马静,程建新.树突状细胞疫苗与妇科肿瘤免疫治疗[J].河北医科大学学报,2009,30(8):854-856. 被引量:1
  • 2FURUKARWA T, WATANABE S, KODAMA T, et al. T-zonehistiocytes in adenocarcinoma of the lung in relation to postoperative prognosis [ J]. Cancer, 1985,56 ( 11 ) : 2651 - 2657.
  • 3STEINMAN RM, COHN ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution [ J ]. J Exp Med, 1973,137 (5) : 1142 - 1162.
  • 4KOHO H, PAULIE S, BEN-AISSA H, et al. Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladder[ J ]. Cancer Immunol Immunother, 1984,17(3) :165 - 172.
  • 5SMITH CA, FARRAH T, GOODWIN RG. The TNF receptor supeffamily of cellular and viral protein : activation,costimulation, and death[ J]. Cell, 1994,76 (6) :959 - 962.
  • 6PHIPPS RP. Atherosclerosis: the emerging role of inflammation and the role CI0-CD40 ligand system [ J ]. Proc Natl Acad Sci USA,2000,97(13) :6930 -6932.
  • 7谷彦军,马洪达,魏焕萍.树突状细胞与乳腺癌[J].国际病理科学与l临床杂志,2006,26(1):31-34.
  • 8TSUJITANI S, KAKEJI Y, WATANABE A, et al. Infiltration of dendritic cells in relation to tumor invasion and lymph node metastasis in human gastric cancer [ J ]. Cancer, 1990,66 ( 9 ) : 2012 -2016.
  • 9FONTENOT JD, GAVIN MA, RUDENSKY AY. FoxP3 programs the development and function of CD4 * CD25 regulatory T cells [ J]. Nat Immuno1,2003,4 (4) :330 - 336.
  • 10NESSELHUT T, MATI'HES C, MARS D, et al. Cancer therapy with immature monocyte-derived dendritic cells in patients with advanced breast cancer [ J ]. Clinnical Oncology, 2005, 23 ( 165 ) :25 - 28.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部